Childhood-onset disease carries a higher risk of low bone mineral density in an adult population of systemic lupus erythematosus

Rheumatology (Oxford). 2012 Mar;51(3):468-75. doi: 10.1093/rheumatology/ker306. Epub 2011 Nov 16.

Abstract

Objective: To study the BMD of patients with SLE according to the age of disease onset.

Methods: Consecutive SLE patients were screened for BMD at the hip, lumbar spine and whole body by the dual-energy X-ray absorptiometry (DXA). Comparison was made between patients who had disease onset in childhood (<18 years) and adulthood (≥18 years). Factors associated with low BMD were studied by linear regression.

Results: A total of 395 SLE patients were studied (94% women; 11% childhood-onset disease). Osteoporosis of the lumbar spine and the hip/femoral neck was present in 20 and 10% of the patients, respectively. Childhood-onset SLE patients were less likely to be post-menopausal, but had significantly lower BMI, longer SLE duration and a higher frequency of ever use of high-dose CSs, CYC and AZA. Despite a significantly younger age, the BMD of the hip, femoral neck and lumbar spine was significantly lower in childhood- than adult-onset SLE patients. In linear regression models, childhood-onset disease was an independent factor for lower BMD at the lumbar spine (β = -0.18; P = 0.002), hip (β = -0.20; P = 0.001) and femoral neck (β = -0.16; P = 0.01) after adjustment for age, sex, BMI, smoking, menopause, SLE duration and damage index, duration and current dose of prednisolone treatment and the ever use of high-dose glucocorticoids, other immunosuppressive agents, calcium, vitamin D and the bisphosphonates.

Conclusions: In adult SLE patients, childhood-onset disease carries a higher risk of osteoporosis, which may possibly be related to a higher cumulative dose of glucocorticoids used for more active disease and failure to achieve a normal peak bone mass during puberty.

Publication types

  • Comparative Study

MeSH terms

  • Absorptiometry, Photon
  • Adolescent
  • Adult
  • Age of Onset*
  • Body Mass Index
  • Bone Density*
  • Cross-Sectional Studies
  • Female
  • Glucocorticoids / adverse effects
  • Glucocorticoids / therapeutic use
  • Hip / physiopathology
  • Humans
  • Incidence
  • Linear Models
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / drug therapy
  • Male
  • Middle Aged
  • Osteoporosis / etiology*
  • Osteoporosis / physiopathology
  • Risk Factors
  • Severity of Illness Index
  • Spine / physiopathology
  • Young Adult

Substances

  • Glucocorticoids